Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer (Q37032851)

From Wikidata
Jump to navigation Jump to search
scientific article published on 05 April 2013
edit
Language Label Description Also known as
English
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
scientific article published on 05 April 2013

    Statements

    Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer (English)
    M M Kim
    P Allen
    W A Woodward
    F Meric-Bernstam
    K K Hunt
    H M Kuerer
    J K Litton
    G N Hortobagyi
    T A Buchholz
    E A Mittendorf
    5 April 2013
    1999-2004

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit